Target discovery and validation in tuberculosis

被引：0
|
作者：
Dick, Thomas [1 ]
机构：
[1] Novartis Inst Trop, Dis Pte, Singapore, Singapore
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [31] Peptide deformylase - a promising therapeutic target for tuberculosis and antibacterial drug discovery
    Sharma, Anshika
    Khuller, Gopal K.
    Sharma, Sadhna
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (07) : 753 - 765
  • [32] Validation of Mycobacterium tuberculosis dihydroneopterin aldolase as a molecular target for anti-tuberculosis drug development
    Falcao, V. C. A.
    Villela, A. D.
    Rodrigues-Junior, V. S.
    Pissinate, K.
    Eichler, P.
    Pinto, A. F. M.
    Basso, L. A.
    Santos, D. S.
    Bizarro, C. V.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 485 (04) : 814 - 819
  • [33] Editorial overview: Cancer: From target discovery to targeted therapy: the risky business of target validation
    Cruzalegui, Francisco
    CURRENT OPINION IN PHARMACOLOGY, 2014, 17 : IV - VI
  • [34] Application of functional Genomics to animal models of alcoholism for target discovery and validation
    Heilig, M
    Hansson, A
    Sommer, W
    Terasmaa, A
    Bjork, K
    Rimondini, R
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S40 - S41
  • [35] Mouse genetics/genomics: An effective approach for drug target discovery and validation
    West, DB
    Iakougova, O
    Olsson, C
    Ross, D
    Ohmen, J
    Chatterjee, A
    MEDICINAL RESEARCH REVIEWS, 2000, 20 (03) : 216 - 230
  • [36] Discovery and validation of a novel checkpoint target preferentially expressed in the tumor microenvironment
    Rajasekaran, Narendiran
    Makkouk, Amani
    Pachynski, Russel K.
    Azameera, Aruna
    Chester, Cariad
    Zhao, Xing
    Yonezawa, Atsushi
    Kohrt, Holbrook E.
    CANCER RESEARCH, 2016, 76
  • [37] Integration of Chromogenic RNAscope In Situ Hybridization for Target Validation in Drug Discovery
    Win, Rosanna
    Minto, Wesley
    Mah, In Kyoung
    Boyd, Kelli
    TOXICOLOGIC PATHOLOGY, 2025,
  • [38] USP7: Target Validation and Drug Discovery for Cancer Therapy
    Zhou, Jin
    Wang, Jinzheng
    Chen, Chao
    Yuan, Haoliang
    Wen, Xiaoan
    Sun, Hongbin
    MEDICINAL CHEMISTRY, 2018, 14 (01) : 3 - 18
  • [39] Target validation and drug discovery efforts on exoribonuclease XRN1
    Lynes, Maureen M.
    Lockbaum, Gordon J.
    Sparling, Brian A.
    Shen, Sophie A.
    Nayak, Sunaina P.
    Knockenhauer, Kevin
    Grigoriu, Simina
    Buker, Shane M.
    Duncan, Kenneth W.
    Copeland, Robert A.
    Blakemore, Stephen J.
    Silver, Serena J.
    Boriack-Sjodin, P. Ann
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (11)
  • [40] Kinase chemogenomics: Targeting the human kinome for target validation and drug discovery
    ter Haar, E
    Walters, WP
    Pazhanisamy, S
    Taslimi, P
    Pierce, AC
    Bemis, GW
    Salituro, FG
    Harbeson, SL
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2004, 4 (03) : 235 - 253
12345